United States · FDA National Drug Code directory
TIADYLT ER
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1040_302fc306-6fbe-4567-b5ce-dcc5a45ba894
- Product NDC
- 70771-1040
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- diltiazem hydrochloride
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171108
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 420 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1040-0) · 70771-1040-0
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1040-1) · 70771-1040-1
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1040-3) · 70771-1040-3
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1040-5) · 70771-1040-5
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1040-9) · 70771-1040-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →